CelLBxHealth (FRA:DWV) Total Operating Expense: €18.90 Mil (TTM As of Dec. 2025)


What is CelLBxHealth Total Operating Expense?

CelLBxHealth FRA:DWV -8.33% Total Operating Expense is €18.90 Mil as of Dec. 2025. The stock has 5 warning signs investors should review.

CelLBxHealth's Total Operating Expense for the six months ended in Dec. 2025 was €6.96 Mil. CelLBxHealth's Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 was €18.90 Mil.

CelLBxHealth Total Operating Expense Related Terms

CelLBxHealth Total Operating Expense Historical Data

* Premium members only.

The historical data trend for CelLBxHealth's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CelLBxHealth Total Operating Expense Chart

CelLBxHealth Annual Data
Trend Apr16 Apr17 Apr18 Apr19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.23 30.73 25.52 20.83 18.56

CelLBxHealth Semi-Annual Data
Apr16 Oct16 Apr17 Oct17 Apr18 Oct18 Apr19 Oct19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.32 10.54 10.07 11.93 6.96

CelLBxHealth Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €18.90 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of €18.90 Mil mean?
CelLBxHealth (FRA:DWV) has a Total Operating Expense of €18.90 Mil as of Dec. 2025. Total operating expense is the primary recurring expense associated with central operations. View historical data on CelLBxHealth and its competitors.
Is CelLBxHealth's Total Operating Expense too high?
CelLBxHealth's current Total Operating Expense is €18.90 Mil.
How does CelLBxHealth's Total Operating Expense compare to TMO and DHR?
CelLBxHealth's Total Operating Expense of €18.90 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Medical Diagnostics & Research company?
A good Total Operating Expense depends on the Medical Diagnostics & Research industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on CelLBxHealth and its competitors. CelLBxHealth's current Total Operating Expense is €18.90 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CelLBxHealth stock overvalued right now?
CelLBxHealth (FRA:DWV) has a current Total Operating Expense of €18.90 Mil. The current Total Operating Expense is €18.90 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For CelLBxHealth (FRA:DWV), the current Total Operating Expense is €18.90 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CelLBxHealth Business Description

Other Exchanges ANPCF:USACLBX:UK
Address 10 Nugent Road, The Surrey Research Park, Surrey, Guildford, GBR, GU2 7AF
CelLBxHealth PLC is active in the healthcare sector in the United Kingdom. The Company's principal trading activity is undertaken in relation to the development and commercialization of the Parsortix cell separation system, with deployment in liquid biopsy that is non-invasive cancer diagnostics. It is a medical diagnostic company specializing in the development of pioneering products in cancer diagnostics. Its patented Parsortix technology can potentially treat and diagnose various forms of cancer. The Parsortix system can capture and harvest CTCs from patient blood. Its geographical segments include Europe and North America, of which the majority of its revenue is generated from Europe.